Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: valsartan

« Back to Dashboard

Summary for Generic Name: valsartan

Tradenames:2
Patents:2
Applicants:2
NDAs:3
Drug Master File Entries: see list27
Suppliers: see list12
Therapeutic Class:Cardiovascular Agents

Pharmacology for Ingredient: valsartan

Tentative approvals for VALSARTAN

Applicant Application No. Form Dosage
<disabled><disabled>TABLET; ORAL80MG
<disabled><disabled>TABLET; ORAL160MG
<disabled><disabled>TABLET; ORAL320MG

Clinical Trials for: valsartan

Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
Status: Recruiting Condition: Hypertension

Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Recruiting Condition: Hypertrophic Cardiomyopathy

Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
Status: Completed Condition: Diabetes Mellitus, Type 2

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan
Status: Completed Condition: Hypertension; Hyperlipidemia

To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
Status: Completed Condition: Hypertension; High Blood Pressure

Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers
Status: Completed Condition: Hypertension, Hyperlipidemia

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ohm Labs Inc
VALSARTAN
valsartan
TABLET;ORAL077492Jun 26, 2014RXNo<disabled><disabled>
Novartis
DIOVAN
valsartan
TABLET;ORAL021283Aug 14, 2002RXNo6,294,197*PED<disabled>Y<disabled>
Novartis
DIOVAN
valsartan
TABLET;ORAL021283Jul 18, 2001RXNo5,972,990*PED<disabled>Y<disabled>
Novartis
DIOVAN
valsartan
CAPSULE;ORAL020665Dec 23, 1996DISCNNo<disabled><disabled>
Novartis
DIOVAN
valsartan
TABLET;ORAL021283Jul 18, 2001RXYes5,972,990*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc